Polymyalgia rheumatica: current management

2017-03-10

Bhaskar Dasgupta

This lecture was recorded at the 2nd McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

See also

Osteoporosis prevention and treatment: when a pharmacologic intervention is justified A lecture by Prof. Jonathan Adachi, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Nonalcoholic fatty liver disease: current management A lecture by Prof. Barry Lumb, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.
Differentiating between PMR and paraneoplastic PMR-like syndromes Malignancies often mimic polymyalgia rheumatica (PMR), especially in the first months of the disease. Are there any distinguishing features of paraneoplastic PMR-like syndromes?
Osteoporosis treatment and the risk of fractures Why should we treat osteoporosis?
Anti-TNF therapy and progression of radiological changes in the spine Does anti-tumor necrosis factor therapy inhibit the progression of radiological changes in the spine?
Rheumatologic emergencies warranting immediate action The majority of patients with rheumatic diseases should be diagnosed and treated within several weeks of symptom onset. What rheumatologic emergencies warrant immediate action?
Giant cell arteritis and other large vessel vasculitis A lecture by Dr Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Behçet disease: Uncommon or underdiagnosed? Is Behçet disease uncommon or rather underdiagnosed? When should it be suspected?
Most common errors in the treatment of gout What are the most common errors in the treatment of gout?
Colchicine in acute gout If colchicine in doses 1 g + 0.5 g is partly ineffective in a patient with acute gout, should it be continued at the same daily dose or is it better to switch to or add a nonsteroidal anti-inflammatory drug or a corticosteroid?

Polymyalgia rheumatica: current management

Social Media